Product Team Cialis: Getting Ready to Market In 1998 Pfizer released Viagra to market approximately six months after the federal Drug Administration (FDA) relaxed regulations on Direct-to-Consumer (DTC) advertising for pharmaceuticals. Viagra‚ which was approved for the treatment of erectile dysfunction (ED) would most likely not have had the same success a without the ability to market directly to patients. Flat sales could have been caused by ED patients are embarrassment‚ primary care physicians
Premium Erectile dysfunction Eli Lilly and Company Advertising
Lecture 10: Product Team Cialis: Getting Ready to Market (case 12) 1-) The most relevant dimensions along which to segment the patient market for the Erectile Dysfuction (ED) treatment are demographic‚ psychographic and behavioral dimensions. With demographic segmentation‚ we divide the market into groups on the basis of variables such as age‚ family size‚ family life cycle‚ gender‚ income‚ occupation‚ education‚ religion‚ race‚ generation‚ nationality and social class. The prevalence of
Premium Sexual intercourse Patient Psychographic
position Cialis in the marketplace?•I suppose that Cialis should follow directly compete strategy and go head by head with Viagra ’s positioning. •Aggressive marketing campaign in US‚ what naturally bleeds into Europe‚ and educational campaigns in other countries (educating partners)•Cialis should emphasize lifestyle and inspirational images•Cialis should emphasize no side effects‚ shorter
Premium Erectile dysfunction Brand management Pharmacology
Product Team Cialis: Getting Ready to Market MKT Q1. In 2002‚ Viagra was the only clinically proven‚ FDA approved medication for Erectile Dysfunction (ED) on the market (Cialis – Dec 2003‚ Levitra – Sept 2003). Viagra had the highest brand recognition of any pharmaceutical product on the market. It had generated over one billion dollars in annual sales for 3 consecutive years since its introduction in 1998. In 2002‚ Viagra accounted for 5.3% ($1.73 billion) in sales of Pfizer’s annual
Premium Marketing Erectile dysfunction
Positioning Case: Product Team Cialis_Getting Ready to Market (HBS 9-505-038) The Actors: - Mark Babato‚ the executive director and global product team leader for Cialis - Rob Brown‚ the global marketing director from Lilly - Leonard Blum‚ vice president of sales and marketing from ICOS - Sidney Taurel‚ Chairman of the Board‚ President and CEO of Lilly Problem Analysis: | |VIAGRA |CIALIS
Premium Marketing Advertising Eli Lilly and Company
1.Problem StatementLilly- ICOS LLC is about to launch a new and innovative product intended to help men suffering from Erectile Dysfunction (ED). Because of the unique product features‚ Cialis - the product - has good chances of becoming successful even though it is entering a segment‚ where Pfizer’s Viagra is the undisputed market leader. In this context‚ Lilly- ICOS LLC must decide on a marketing strategy‚ in particular which groups to target and which positioning thus which communication strategy
Premium Marketing Target market
Introduction The new medicine named Cialis is getting ready to the market.By Customer analysis‚ SWOT analysis‚a decision each of the marketing mix is taken to compliment the strategy chosen based on the competencies and resources of the product team. Consumer Analysis: Who? 150 million men worldwide (Chronic) and 50% of all men (40-70) What? Onset; Safety with Nitrates; Duration; Time on market When? They purchase after consultation‚ with family doctor; urologist or men’s specialist;
Premium Marketing Eli Lilly and Company
1) What are the most relevant dimensions along which to segment the patient market for ED treatment? Of the segments identified‚ which would you target initially with Cialis? The relevant dimensions are: age‚ occupation‚ marital/partner status‚ level of education‚ level of income and ED medication use habits (i.e. Viagra dropout). Within these segments‚ the populations to target are: • Age: Men ages 50+ (slight market with men ages 40-49) • Occupation: Retired or employed full time • Marital
Premium Marketing Erectile dysfunction Eli Lilly and Company
Cialis Case Analysis I. Problem: Lilly ICOS LLC (“Lily”)‚ a young biotech start-up‚ is going to launch a new drug Cialis for male impotence treatment. In the existing ED drug market‚ Viagra has gained a huge success and Pfizer is accelerating its marketing pace. The problem with Lily is which patient segment to target and how to position itself in the marketplace in launching the Cialis. II. Alternatives: 1) Follow a Beat Strategy and Come Up with a Differentiated Positioning + High profit
Premium Marketing Erectile dysfunction Eli Lilly and Company
Cialis Cialis is an erectile dysfunction medication attempting to enter the market that is already dominated by Viagra. Viagra’s dominance in the market‚ along with Levitra’s entrance on the scene‚ it caused Lilly ICOS LLC to question how they should position Cialis with their unique capabilities. In order for Cialis to become successful in the market‚ they can either use a beat strategy‚ compete strategy‚ or niche strategy. Before implementing these solutions‚ a set of criteria is needed to determine
Premium Marketing Target market Eli Lilly and Company